Issue 16, 2021

Two polymorphs of remdesivir: crystal structure, solubility, and pharmacokinetic study

Abstract

Two polymorphic phases of the antiviral drug remdesivir (RDV), namely RDV-I and RDV-II are prepared and structurally characterized by single-crystal X-ray diffraction. Both RDV-I and RDV-II are solvent-free but exhibit different packing patterns in their crystals. RDV-I and RDV-II feature different pharmacokinetics, as revealed by in vitro and in vivo studies. This work highlights the significance of remdesivir drug formulations on the pharmacokinetics and ultimately patient outcome when combating the coronavirus disease 2019 (Covid-19).

Graphical abstract: Two polymorphs of remdesivir: crystal structure, solubility, and pharmacokinetic study

Supplementary files

Article information

Article type
Communication
Submitted
04 Febr. 2021
Accepted
30 Marts 2021
First published
01 Apr. 2021

CrystEngComm, 2021,23, 2923-2927

Two polymorphs of remdesivir: crystal structure, solubility, and pharmacokinetic study

K. Yu, S. Chen, C. Amgoth, G. Tang, H. Bai and X. Hu, CrystEngComm, 2021, 23, 2923 DOI: 10.1039/D1CE00175B

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements